Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
12.13
+0.06 (+0.50%)
Range 11.79 - 12.43
Open 12.25
Prev Close 12.07
52 Week 5.60 - 13.88
Volume 724458
Market Cap 1.26B
*Delayed 8/27/2015 4:00 EDT

 
Form 8937 for 2015 Reverse Stock Split

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000